Hyponatremia is a frequent electrolyte disturbance after cardiac surgery and may result from several simultaneous mechanisms, including non-osmotic antidiuretic hormone (ADH) release, diuretic exposure, reduced effective circulating volume and administration of hypotonic fluids. Distinguishing hypovolemic hyponatremia from syndrome of inappropriate antidiuresis (SIAD) can be challenging, particularly when these processes coexist.
A 77-year-old man with long-standing hypertension presented with chest pain radiating to the left arm and was diagnosed with an anterior wall myocardial infarction. Coronary angiography revealed triple-vessel coronary artery disease, for which he underwent off-pump coronary artery bypass grafting (CABG) with four grafts. His immediate postoperative haemodynamic course was stable, and he was successfully extubated. During subsequent recovery, he developed breathlessness and desaturation on mobilization and was treated with oxygen, chest physiotherapy, nebulization and diuretics. Renal function and electrolytes were initially preserved. On postoperative day 9, he developed severe hyponatremia (serum sodium 117 mmol/L), accompanied by giddiness, postural hypotension and clinical evidence of volume depletion while receiving diuretic therapy. Urine osmolality was 553 mOsm/kg, spot urine sodium 101 mmol/L and serum uric acid 2.11 mg/dL. Thyroid and cortisol assessments were reported as normal, and renal function remained preserved. Diuretics were withheld, volume status was addressed and 3% hypertonic saline was administered with serial sodium monitoring. Sodium initially increased only minimally, followed by gradual improvement to 133 mmol/L by postoperative day 13. The patient became clinically euvolemic and was discharged in a stable condition. Tolvaptan was continued for a suspected persistent SIAD-like component and subsequently discontinued after follow-up demonstrated normalization of serum sodium.
This case illustrates the diagnostic complexity of postoperative hyponatremia when volume depletion and persistent antidiuretic activity may overlap. Urine indices must be interpreted in the context of diuretic exposure and bedside volume assessment. Careful correction and close monitoring are essential to avoid overly rapid sodium correction.
Keywords: Hyponatremia; CABG; cardiac surgery; hypovolemia; SIAD; antidiuretic hormone.
Hyponatremia is commonly encountered in hospitalized patients and is particularly relevant after cardiac surgery. Surgical stress, pain, nausea, pulmonary complications, haemodynamic changes and medications can stimulate non-osmotic ADH release. In parallel, loop or thiazide diuretics, reduced oral intake and fluid losses may produce extracellular volume depletion. These mechanisms can coexist, creating a mixed clinical and biochemical picture.
The distinction between hypovolemic hyponatremia and SIAD is clinically important because their treatments differ. Volume-depleted patients generally require restoration of circulating volume, whereas fluid restriction and selected pharmacological therapies may be considered in persistent euvolemic SIAD. Urine sodium and osmolality are useful, but neither should be interpreted in isolation, particularly in patients receiving diuretics.
A 77-year-old gentleman with long-standing systemic hypertension presented with chest pain radiating to the left upper limb and was diagnosed with an anterior wall myocardial infarction. Coronary angiography demonstrated triple-vessel coronary artery disease, and he was advised surgical revascularization. He underwent off-pump CABG with four grafts: left internal mammary artery to the left anterior descending artery, and saphenous vein grafts to the major obtuse marginal branch, the last obtuse marginal branch and the posterior descending artery. Right radial artery repair was also performed.
The immediate postoperative period was haemodynamically stable. He was weaned from mechanical ventilation and extubated. Subsequently, he experienced breathlessness and oxygen desaturation during mobilization, for which supplemental oxygen, chest physiotherapy, nebulization and diuretic therapy were administered. Initial renal function and serum electrolytes were within normal limits. Echocardiography showed postoperative paradoxical septal motion, adequate left ventricular systolic function and a left ventricular ejection fraction of 53%.
On postoperative day 9, serum sodium was found to be 117 mmol/L, prompting nephrology consultation. He reported giddiness and had postural hypotension with clinical features suggestive of volume depletion. He was receiving diuretic infusion at the time. The calculated sodium deficit was addressed with 3% hypertonic saline, with a planned gradual correction and serial monitoring. On the following day, serum sodium was 118 mmol/L, indicating only a limited initial response.
Further evaluation showed urine osmolality of 553 mOsm/kg, spot urine sodium of 101 mmol/L and serum uric acid of 2.11 mg/dL. Thyroid function and cortisol were reported to be normal, and renal function was preserved. The concentrated urine indicated ongoing antidiuretic activity. The high urine sodium and low serum uric acid raised the possibility of an SIAD-like component; however, interpretation was complicated by concurrent diuretic exposure and clinical evidence of hypovolemia.
Diuretics were withheld initially, volume depletion was corrected and hypertonic saline therapy was continued along with Tab.Tolvaptan with close biochemical monitoring. Serum sodium gradually improved and reached 133 mmol/L by postoperative day 13. The patient became clinically euvolemic, and renal function remained stable. He was discharged in a stable condition. Tolvaptan was prescribed for a suspected persistent SIAD component and was subsequently stopped at follow-up after serum sodium had normalized.
Postoperative hyponatremia after CABG is often multifactorial. Cardiopulmonary and surgical stress, pain, nausea, pulmonary disease and haemodynamic stimuli can promote non-osmotic ADH secretion. ADH increases collecting-duct water reabsorption, leading to impaired free-water excretion and a fall in serum sodium when water intake or administration exceeds excretory capacity.
At the same time, diuretic therapy and reduced intake can contribute to extracellular volume depletion. Hypovolemia is itself a potent stimulus for ADH release, even when plasma osmolality is low. Thus, a patient may have clinically important volume depletion together with concentrated urine and impaired water excretion. This overlap may be described as mixed-mechanism hyponatremia or, more cautiously, hypovolemic hyponatremia with persistent ADH activity.
A urine osmolality of 553 mOsm/kg demonstrates that the kidney was not producing maximally dilute urine and is consistent with active antidiuresis. It does not, by itself, establish SIAD, because appropriate ADH secretion in response to hypovolemia can produce the same finding. A spot urine sodium of 101 mmol/L may support SIAD in an appropriate setting, but diuretics can increase urinary sodium excretion and make this parameter unreliable for differentiating SIAD from hypovolemia. A low serum uric acid concentration can occur in SIAD but is not diagnostic in isolation.
Classical diagnostic criteria for SIAD include hypotonic hyponatremia, inappropriately concentrated urine, clinical euvolemia, urine sodium generally above 30 mmol/L with adequate dietary salt intake, and exclusion of adrenal, thyroid and significant renal dysfunction. Recent diuretic use and clear clinical hypovolemia complicate application of these criteria. Accordingly, the most defensible interpretation in this case is multifactorial postoperative hyponatremia with volume depletion and a possible additional SIAD-like component, rather than unequivocally proven SIAD.
Management should be guided by symptom severity, chronicity, volume status and the suspected mechanism. In patients with significant neurological symptoms attributable to hyponatremia, hypertonic saline is used to achieve an initial modest rise in serum sodium, commonly approximately 4–6 mmol/L, rather than immediate normalization. For chronic or duration-uncertain hyponatremia, correction should generally be limited to no more than 8 mmol/L in any 24-hour period; a more conservative limit is appropriate in patients at high risk of osmotic demyelination.
When hypovolemia is present, withdrawal of contributing diuretics and careful restoration of effective circulating volume are important. Following volume repletion, endogenous ADH secretion may fall abruptly, resulting in a water diuresis and unexpectedly rapid sodium correction. Frequent measurement of serum sodium and urine output is therefore essential during treatment.
Tolvaptan, a vasopressin V2-receptor antagonist, may be considered in selected patients with persistent euvolemic or hypervolemic hyponatremia due to SIAD or other appropriate indications. It should not be used to treat hypovolemic hyponatremia because aquaresis can aggravate volume depletion and cause rapid sodium correction. If considered after the patient is demonstrably euvolemic, initiation requires careful patient selection and close monitoring of serum sodium, fluid balance and clinical status.
The paradox in this case lies in the coexistence of clinical findings suggestive of volume depletion with biochemical evidence of persistent antidiuretic activity. Diuretic exposure may have contributed to sodium loss and hypovolemia, while postoperative stress and pulmonary or haemodynamic stimuli may have sustained ADH release. These processes are not mutually exclusive. Recognizing this overlap prevents an overly simplistic interpretation of urine sodium and osmolality and supports a sequential, physiology-based approach to treatment.
This case highlights the “hyponatremia paradox” following CABG, in which volume depletion and persistent antidiuretic activity may coexist. Accurate diagnosis requires integration of clinical volume assessment, medication history and biochemical findings. A cautious, mechanism-directed approach with frequent monitoring is essential to achieve safe correction and avoid complications.
Dr S Karthikeyan, Postgraduate in Nephrology Kauvery Hospital, Chennai.
Dr R. Balasubramaniam, Chief Nephrologist and Senior Consultant Kauvery Hospital, Chennai.